| ID | 69877 |
| FullText URL | |
| Author |
Kubo, Toru
Department of Cardiology and Geriatrics, Kochi Medical School, Kochi University
Maekawa, Yuichiro
Division of Cardiology, Internal Medicine III, Hamamatsu University School of Medicine
Hongo, Kenichi
Division of Cardiology, Department of Internal Medicine, The Jikei University School of Medicine
Yamamoto, Saori
Department of Cardiovascular Medicine, Tohoku University Graduate School of Medicine
Izumiya, Yasuhiro
Department of Cardiovascular Medicine, Osaka Metropolitan University, Graduate School of Medicine
Yamakawa, Hiroyuki
Department of Cardiology, Keio University School of Medicine
Yano, Toshiyuki
Department of Cardiovascular, Renal and Metabolic Medicine, Sapporo Medical University School of Medicine
Higuchi, Koji
Department of Cardiovascular Medicine and Hypertension, Graduate School of Medical and Dental Sciences, Kagoshima University
Kuramoto, Yuki
Department of Cardiovascular Medicine, The University of Osaka Graduate School of Medicine
Nakagawa, Naoki
Division of Cardiology and Nephrology, Department of Internal Medicine, Asahikawa Medical University
Amano, Masashi
Department of Heart Failure and Transplantation, National Cerebral and Cardiovascular Center
Yamada, Yu
Department of Cardiology, Institute of Medicine, University of Tsukuba
Oikawa, Masayoshi
Department of Cardiovascular Medicine, Fukushima Medical University
Iida, Yuichiro
Department of Cardiovascular Medicine, Kitasato University School of Medicine
Tsujita, Kenichi
Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto University
Matsue, Yuya
Department of Cardiovascular Biology and Medicine, Juntendo University Graduate School of Medicine
Izawa, Hideo
Department of Cardiology, Fujita Health University
Suzuki, Atsushi
Department of Cardiology, Tokyo Women's Medical University
Nagatomo, Yuji
Department of Cardiology, National Defense Medical College
Nagai, Toshiyuki
Department of Cardiovascular Medicine, Faculty of Medicine and Graduate School of Medicine, Hokkaido University
Kida, Keisuke
Department of Pharmacology, St. Marianna University School of Medicine
Nakamura, Kazuto
Department of Cardiovascular Medicine, University of Yamanashi, Faculty of Medicine
Nakamura, Kazufumi
Center for Advanced Heart Failure, Okayama University Hospital
Kaken ID
publons
researchmap
Ikenaga, Hiroki
Department of Cardiovascular Medicine, Hiroshima University Graduate School of Biomedical and Health Sciences
Kanda, Takahiro
Department of Internal Medicine, Division of Cardiology, Hamamatsu Red Cross Hospital
Kinugasa, Yoshiharu
Department of Cardiovascular Medicine and Endocrinology and Metabolism, Faculty of Medicine, Tottori University
Ito, Hiromasa
Department of Cardiology, Mie University Hospital
Onoue, Kenji
Department of Cardiovascular Medicine, Nara Medical University
Kanamori, Hiromitsu
Department of Cardiology, Gifu University Graduate School of Medicine
Kitaoka, Hiroaki
Department of Cardiology and Geriatrics, Kochi Medical School, Kochi University
|
| Abstract | Background: Fabry disease (FD) is an important disease in the cardiovascular field because a significant proportion of patients with FD die from cardiac lesions.
Methods: A multicenter prospective registration study of patients with FD throughout Japan was designed. The baseline clinical characteristics of 175 patients are presented here. Results: The mean ages at enrolment and at diagnosis were 52 ± 16 and 43 ± 18 years, respectively, with men accounting for 38 % of the patients. In the cohort, 24 % of the patients had the classical hemizygote male type, whereas 14 % had the late-onset male type, and 62 % had the heterozygote female type. On electrocardiography data at enrolment in 92 patients with left ventricular hypertrophy (LVH) (maximum LV wall thickness > 12 mm), 12 % showed a short PQ interval (< 120 msec), and 33 % had a short PendQ interval (≤ 40 msec). The Sokolow-Lyon voltage was high (6.1 ± 13.1 mv). Regarding the distribution of LVH patterns, 77 % of the patients showed concentric diffuse LVH, 16 % of the patients had asymmetric septal hypertrophy, and 1 % of the patients had hypertrophy confined to the LV apex. With regard to implantation of cardiac devices, permanent pacemakers had been implanted in 5 % of the patients and defibrillators had been implanted in 12 patients (7 %), for primary prevention in nine patients and for secondary prevention in three patients. Conclusion: As the first large-scale prospective registry of FD patients in Japan, this study has provided valuable baseline data for the cardiac features and management of FD. |
| Keywords | Fabry disease
Prospective study
Left ventricular hypertrophy
Treatment
|
| Published Date | 2026-02-15
|
| Publication Title |
International Journal of Cardiology
|
| Volume | volume445
|
| Publisher | Elsevier BV
|
| Start Page | 134071
|
| ISSN | 0167-5273
|
| NCID | AA10623832
|
| Content Type |
Journal Article
|
| language |
English
|
| OAI-PMH Set |
岡山大学
|
| Copyright Holders | © 2025 The Authors.
|
| File Version | publisher
|
| PubMed ID | |
| DOI | |
| Related Url | isVersionOf https://doi.org/10.1016/j.ijcard.2025.134071
|
| License | http://creativecommons.org/licenses/by/4.0/
|